Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Exchange Rate Effect (2023 - 2025)

Lisata Therapeutics (LSTA) has disclosed Exchange Rate Effect for 6 consecutive years, with $2000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 94.87% year-over-year to $2000.0, compared with a TTM value of -$56000.0 through Sep 2025, up 15.15%, and an annual FY2024 reading of -$55000.0, down 243.75% over the prior year.
  • Exchange Rate Effect was $2000.0 for Q3 2025 at Lisata Therapeutics, down from $5000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $75000.0 in Q3 2023 and bottomed at -$76000.0 in Q4 2023.
  • Average Exchange Rate Effect over 3 years is -$5636.4, with a median of $2000.0 recorded in 2025.
  • Peak annual rise in Exchange Rate Effect hit 425.0% in 2024, while the deepest fall reached 685.71% in 2024.
  • Year by year, Exchange Rate Effect stood at -$76000.0 in 2023, then increased by 14.47% to -$65000.0 in 2024, then soared by 103.08% to $2000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for LSTA at $2000.0 in Q3 2025, $5000.0 in Q2 2025, and $2000.0 in Q1 2025.